Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year

Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year

PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD). MATERIALS AND METHODS: Patients with treatment-naïve eAMD treated with pro re nata (PRN)...

Full description

Bibliographic Details
Main Authors: Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
age-related macular degeneration
antivascular endothelial growth factor
bevacizumab
ziv-aflibercept
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2020;volume=10;issue=4;spage=289;epage=293;aulast=Singh

Internet

http://www.e-tjo.org/article.asp?issn=2211-5056;year=2020;volume=10;issue=4;spage=289;epage=293;aulast=Singh

Similar Items